Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nicotine addiction.

N L Benowitz1

  • 1Departments of Medicine, Psychiatry, and Biopharmaceutical Sciences, University of California, San Francisco 94143-1220, USA. nbeno@itsa.ucsf.edu

Primary Care
|August 7, 1999
PubMed
Summary
This summary is machine-generated.

Nicotine addiction, driven by its action on brain receptors, is severe in individuals with mental health issues. Cigarettes efficiently deliver nicotine, but current assessment tools struggle to predict the difficulty in quitting tobacco use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gender differences in the pharmacology of nicotine addiction.

Addiction biology·2016
Same author

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.

Clinical pharmacology and therapeutics·2014
Same author

Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers.

Clinical pharmacology and therapeutics·2013
Same author

CYP2A6 genotype but not age determines cotinine half-life in infants and children.

Clinical pharmacology and therapeutics·2013
Same author

CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.

Clinical pharmacology and therapeutics·2012
Same journal

Primary Care at the Center of America's Mental Health Landscape.

Primary care·2026
Same journal

We Care, and We Will Listen.

Primary care·2026
Same journal

Addressing Sexual Health in Primary Care.

Primary care·2026
Same journal

Diagnosis and Management of Eating Disorders in Adolescents and Young Adults.

Primary care·2026
Same journal

Management of Concomitant Mental Health Conditions in Older Adults with Cognitive Impairment.

Primary care·2026
Same journal

Nonpharmacologic Management of Insomnia Disorder in Primary Care.

Primary care·2026
See all related articles

Area of Science:

  • Neuroscience
  • Addiction Science
  • Pharmacology

Background:

  • Nicotine is the primary agent maintaining tobacco addiction.
  • Nicotine exerts its effects via diverse nicotinic cholinergic receptors in the nervous system.
  • Nicotine addiction severity is often higher in individuals with a history of major depression, schizophrenia, or substance abuse.

Purpose of the Study:

  • To review the mechanisms underlying nicotine addiction.
  • To discuss the role of nicotinic cholinergic receptors in nicotine's actions.
  • To highlight the challenges in assessing and predicting the cessation of tobacco use.

Main Methods:

  • Review of existing literature on nicotine pharmacology and addiction.
  • Analysis of the role of nicotinic cholinergic receptors in the central nervous system.

Related Experiment Videos

  • Discussion of assessment tools for nicotine addiction severity.

    • Main Results:

    • Nicotine's rapid delivery by cigarettes optimizes self-administration.
    • Nicotinic receptor diversity influences nicotine's varied effects.
    • Current assessment tools like the Fagerström Tolerance Questionnaire and DSM-IV are imprecise for predicting cessation difficulty.

    Conclusions:

    • Nicotine addiction is a complex neurobiological and behavioral phenomenon.
    • The efficient delivery system of cigarettes contributes significantly to addiction.
    • Improved methods are needed to predict and address the difficulty in quitting tobacco use.